Abera Bioscience AB announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was SEK 460,000 compared to SEK 169,000 a year ago. Operating loss was SEK 2.194 million compared to SEK 838,000 a year ago. Net loss was SEK 2.194 million compared to SEK 838,000 a year ago. For the half year, total revenue was SEK 463,000 compared to SEK 475,000 a year ago. Operating loss was SEK 4.619 million compared to SEK 1.301 million a year ago. Net loss was SEK 4.619 million compared to SEK 1.301 million a year ago.